Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS)
CNY 25.56
(1.43%)
CNY 25.56
(1.43%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.96 CNY | 47.69% |
| 2022 | 0.65 CNY | -30.85% |
| 2021 | 0.94 CNY | -18.26% |
| 2020 | 1.15 CNY | -30.72% |
| 2019 | 1.66 CNY | -16.16% |
| 2018 | 1.98 CNY | -50.38% |
| 2017 | 3.99 CNY | 149.38% |
| 2016 | 1.60 CNY | -1.84% |
| 2015 | 1.63 CNY | 10.88% |
| 2014 | 1.47 CNY | 48.48% |
| 2013 | 0.99 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.24 CNY | -11.11% |
| 2024 Q1 | 0.27 CNY | 443.07% |
| 2024 Q3 | 0.21 CNY | -12.5% |
| 2023 FY | - CNY | 47.69% |
| 2023 Q3 | 0.36 CNY | -16.28% |
| 2023 Q2 | 0.43 CNY | 168.75% |
| 2023 Q1 | 0.16 CNY | 167.11% |
| 2023 Q4 | -0.08 CNY | -121.86% |
| 2022 Q2 | 0.23 CNY | -23.33% |
| 2022 Q1 | 0.30 CNY | 336.05% |
| 2022 FY | - CNY | -30.85% |
| 2022 Q4 | 0.06 CNY | -57.21% |
| 2022 Q3 | 0.14 CNY | -39.13% |
| 2021 Q2 | 0.23 CNY | -43.9% |
| 2021 Q1 | 0.41 CNY | 57.69% |
| 2021 Q3 | 0.24 CNY | 4.35% |
| 2021 Q4 | 0.07 CNY | -71.33% |
| 2021 FY | - CNY | -18.26% |
| 2020 FY | - CNY | -30.72% |
| 2020 Q4 | 0.26 CNY | 4.0% |
| 2020 Q2 | 0.44 CNY | 120.0% |
| 2020 Q1 | 0.20 CNY | -48.72% |
| 2020 Q3 | 0.25 CNY | -43.18% |
| 2019 Q3 | 0.34 CNY | -46.03% |
| 2019 Q1 | 0.31 CNY | -61.25% |
| 2019 FY | - CNY | -16.16% |
| 2019 Q4 | 0.39 CNY | 14.71% |
| 2019 Q2 | 0.63 CNY | 103.23% |
| 2018 Q2 | 0.51 CNY | 50.0% |
| 2018 FY | - CNY | -50.38% |
| 2018 Q4 | 0.80 CNY | 90.48% |
| 2018 Q3 | 0.42 CNY | -17.65% |
| 2018 Q1 | 0.34 CNY | -30.61% |
| 2017 FY | - CNY | 149.38% |
| 2017 Q3 | 0.30 CNY | 0.0% |
| 2017 Q4 | 0.49 CNY | 63.33% |
| 2016 FY | - CNY | -1.84% |
| 2015 FY | - CNY | 10.88% |
| 2014 FY | - CNY | 48.48% |
| 2013 FY | - CNY | 0.0% |